Spring Obesity Summit 2019

Date: April 5-7
Accreditation: 17.5 CME/CE
Level: Introductory/Intermediate/Advanced

Dive deep into learning about obesity-related diseases at the 2019 Spring Obesity Summit! Gain a deeper understanding of the full picture of how obesity impacts your patients' health, and what you can do about it. You'll gain practical tips and tools to take back and implement immediately in your practice.

The content of the Spring Obesity Summit is appropriate for almost any healthcare provider – so whether you’re in primary care and want more tools to treat patients with obesity, or whether you’re looking to make a career shift into obesity medicine, or whether you’re already deeply ingrained in obesity medicine practice, the Spring Obesity Summit has something for you!

What's New?

  • All-new content and speaker lineup
  • One day focused entirely on adiposity-related disease
  • Day of debate with leading experts engaging in lively point/counterpoint discussions
  • Separate tracks for primary care providers and obesity medicine specialists
  • Real-life case studies demonstrating practical application of techniques

Schedule on Friday, April 5

Friday's focus is on treating adiposity-related diseases in both the primary care and specialist practice settings. "Adiposity-related diseases" refers to chronic diseases and conditions associated with obesity.

6:30-7:15 AM - Walk with the Doc

Start your morning with a fast-paced walk led by Lydia Alexander, MD, FOMA.

7:00-7:45 AM - Q&A Panel Breakfast

Submit your questions in advance through the mobile app for this Q&A panel discussion. This event is worth 0.75 CME/CE credits.

8:00-8:30 AM - Welcome Address

Wendy Scinta, MD, MS, FOMA, and Claudia Randall, MBA

Hear from the OMA President and Executive Director about trends in the field of obesity medicine, expectations for 2019, and OMA projects on the horizon.

8:30-9:30 AM - Keynote Address - Obesity: Applying the Chronic Care Model for Prevention and Management

Eduardo Sanchez, MD, MPH, FAAFP

Dr. Eduardo Sanchez serves as Chief Medical Officer (CMO) for Prevention and Chief of the Center for Health Metrics and Evaluation for the American Heart Association (AHA). Prior to joining AHA, he served as Vice President and CMO for Blue Cross and Blue Shield of Texas (BCBSTX) where he focused on worker and worksite wellness, clinical prevention, and chronic disease management, particularly diabetes and cardiovascular diseases. Dr. Sanchez led the Institute for Health Policy at the University of Texas (UT) School of Public Health as Director from 2006 to 2008. From 2001 to 2006, he served as Texas Commissioner of Health, Texas’ state health officer. He led the Texas Department of State Health Services from 2004 to 2006 and the Texas Department of Health from 2001 to 2004. And he served as the local public health officer in Austin-Travis County from 1994 to 1998.

9:30-10:30 AM - The Future of Obesity Medicine: Managing Adiposity-related Disease with Obesity Treatment


Set the stage for a day of learning about managing adiposity-related diseases.

  • Review the metabolic and fat-mass effects on adiposity-related diseases.
  • Discuss the impact of obesity treatment on metabolic and fat-mass adiposity-related diseases.
  • Explore future options for obesity treatment.

10:30-11:15 AM - Break in Exhibit Hall

Visit the exhibitors and explore the latest technologies, products, and services for your practice.

11:15 AM-12:15 PM - Adiposity-related Disease Breakout Sessions
Insulin Resistance / Lipedema

Primary Care Provider Track
Early Detection and Management of Insulin Resistance

    Lydia Alexander, MD, FOMA, Dipl. ABOM

    • Understand the role of obesity in the pathophysiology of insulin resistance.
    • Recognize the manifestations of insulin resistance in patient history, physical examination, laboratory, and other testing.
    • Identify risks for future adiposity-related diseases based on manifestations of insulin resistance.
    • Understand key interventions for treating and managing patients with insulin resistance.

    Obesity Medicine Specialist Track
    Lipedema: Fat Resistant to Lifestyle Change

    Karen L. Herbst, MD, PhD

    • Review the criteria for diagnosing lipedema.
    • Learn about the pathophysiology of lipedema.
    • Review available studies on the prevalence of lipedema.
    • Identify differences between lipedema, obesity, and lymphedema.
    • Explore the recommended treatment approaches for lipedema.
    • Understand the other diseases associated with lipedema.

12:15-1:15 PM - Lunch in Exhibit Hall

Visit the exhibitors and explore the latest technologies, products, and services for your practice.

1:15-2:15 PM - Adiposity-related Disease Breakout Sessions
Obesity and Sleep / NAFLD

Primary Care Provider Track
The Relationship between Obesity and Sleep

Craig Primack, MD, FACP, FAAP, FOMA, Dipl. ABOM

  • Understand the impact that obesity has on sleep and the impact that dysfunctional sleep patterns have on obesity.
  • Review common sleep-related disorders.
  • Understand the effects of poor sleep habits on weight management.
  • Understand the impact of obesity on sleep disorders, including obstructive sleep apnea.

Obesity Medicine Specialist Track
Managing Non-Alcoholic Fatty Liver Disease (NAFLD) in Pediatric Patients

Sara Karjoo, MD, Dipl. ABOM

  • Understand the pathomechanism of why NAFLD occurs in children with obesity.
  • Review the diseases that have to be ruled out.
  • Explore the possible link between NAFLD and cardiac disease and why it is important to address this in children early on.
  • Explore the link between NAFLD in children and other potential disease states.
  • Learn about available treatment options for pediatric patients with NAFLD.

2:15-3:00 PM - Break in Exhibit Hall

Visit the exhibitors and explore the latest technologies, products, and services for your practice.

3:00-4:00 PM - Adiposity-related Disease Breakout Sessions
Cardiovascular Disease / Anti-obesity Medication Selection

Primary Care Provider Track
Cardiovascular Disease in Patients with Obesity

Eduardo Sanchez, MD, MPH, FAAFP

  • Explore the link between cardiovascular disease and obesity.

Obesity Medicine Specialist Track
Customizing Anti-Obesity Medication Selection for Patients with Adiposity-related Diseases

Louis J. Aronne, MD, FACP, Dipl. ABOM

  • Understand the indications, contra-indications, interactions, mechanisms of action, adverse side effects, and precautions for medications that are commonly used in obesity medicine to manage or prevent adiposity-related disease.
  • Become familiar with the effect of these medications on obesity-related diseases.
  • Understand what medications may also have a positive or negative effect on conditions not related to obesity.

4:15-5:30 PM - Cancer Attributable to the Disease of Obesity

Farhad Islami, MD, PhD

  • Understand why excess body weight is an established cause of cancer.
  • Discuss the link between obesity and cancer.
  • Learn about individual and community-level interventions.

6:00-7:30 - Wild West Member Appreciation and Obesity Treatment Foundation Reception

Saddle up and kick up your boots at this Western-themed reception featuring refreshments and live entertainment. Make sure to dress in your best Western wear for this reception!

Schedule on Saturday, April 6

Saturday is a day of debate, where experts from both sides of the coin will engage in lively point/counterpoint discussions about some of the hottest topics in obesity medicine. After hearing both perspectives, you decide which side you are on.

6:00-7:00 AM - 5k Fun Run

Get your blood pumping during a morning fun run led by Karli Burridge, PA-C.

6:45-7:45 AM - Breakfast and Product Showcase

Learn about rare genetic disorders related to obesity. (No CME/CE credit offered.) Sponsored by Rhythm Pharmaceuticals.

8:00-10:00 AM - Optimizing Obesity Treatment with Pharmacology Point/Counterpoint Discussion

Andres Acosta, MD, PhD, Dipl. ABOM, and Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS, Dipl. ABOM

How do you incorporate anti-obesity medications into treatment with your patients? Is there a benefit to medication alone in patients who are unable to adopt behavioral interventions, or who are already engaged in other lifestyle interventions? Or, should obesity treatment always consist of a comprehensive treatment program that includes nutrition, physical activity, behavior, and medication?

During this point/counterpoint discussion, hear two different experts review the evidence on utilizing anti-obesity medications.

  • Understand the components of a comprehensive weight management program.
  • Familiarize yourself with the medical evidence supporting the efficacy and long-term outcomes for managing adiposity-related diseases.
  • Contrast the utilization of a multi-component interventional program versus medication alone or other modifications in obesity treatment plans based upon the individual patient’s needs and/or available resources.
  • Understand a potential role for individualized obesity treatment interventions in select patients.

10:00-10:15 AM - Break

10:15 AM-12:15 PM - Managing Dyslipidemia in Patients with Obesity Point/Counterpoint Discussion

Harold Bays, MD, FTOS, FACC, FACE, FNLA, FOMA, Dipl. ABOM, and Blair O'Neill, MD, FACC

In patients with high LDL cholesterol, pharmacotherapy is the primary treatment option. But what’s the optimal treatment approach for patients with mixed lipid presentations? During this point/counterpoint discussion, learn about the strengths and limitations of pharmacological treatment vs. lifestyle therapy for dyslipidemia.

  • Learn the essential concepts of lipid analysis, lipid particles, and other markers of dyslipidemia specifically in patients with obesity.
  • Explore the role of individual lipid components in cardiovascular risk assessment.
  • Recognize the strengths and limitations of lifestyle intervention in lipid management.
  • Identify the strengths and limitations of pharmacotherapy in the reduction or prevention of cardiovascular disease.
  • Familiarize yourself with the effects of intensive lifestyle on lipids and inflammatory markers.
  • Understand how to assess cardiovascular risk in patients with obesity and lipid disorders and when advanced lipid analysis and/or alternative risk markers may be useful.
  • Learn how to effectively individualize the treatment of lipid disorders in patients treated for obesity.

12:15-2:15 PM - Extended Lunch Break

Use this time to explore Houston! Lunch will not be provided.

2:15-4:15 PM - The Carbohydrate-Insulin Model Point/Counterpoint Discussion

David S. Ludwig, MD, PhD, and Michael Rosenbaum, MD

What are the underlying driving forces behind the development of obesity? What role does macronutrient composition and insulin-signaling play, versus energy imbalance from excess calorie intake? Listen to this point/counterpoint discussion with experts from two different sides of the debate, then decide for yourself!

  • Understand the roles of total dietary energy content and macronutrient composition in obesity and adiposity-related disease.
  • Explore the pros and cons of the carbohydrate-insulin model as the primary explanation for obesity and its consequences.
  • Explore the pros and cons of energy imbalance as the primary explanation for obesity and its consequences.

6:00 PM - Dine-arounds

Need dinner plans? Sign up at the member center onsite to attend a dine-around! We'll make a reservation at a restaurant near the hotel, so you can join a small group of fellow clinicians for an evening out.*

*Dinner costs are each individual's responsibility.

Schedule on Sunday, April 7

Wrap up the conference learning about some of the other hot topics in obesity medicine and reviewing real-life case studies demonstrating how to apply what you've learned throughout the conference in clinical practice.

7:00-7:45 AM - Breakfast with the Experts

Each table will be assigned a topic related to obesity medicine. Choose a table with a topic that interests you and discuss that topic with an expert over breakfast! This event is worth 0.75 CME/CE credits.

  • Ketogenic diets
  • Very low-calorie diets
  • Low-carb diets
  • Pharmacotherapy
  • Physical activity
  • Behavior modification
  • Partnering with surgeons
  • Weight maintenance
  • Pediatric obesity
  • Thyroid
  • Diabetes
  • Hormones
  • Meal replacements
  • Setting up an obesity medicine practice
  • Advocacy

8:00-9:00 AM - Set Point Theory

  • Explore the Set Point Theory as an explanation for why patients experience difficulties in maintaining weight loss.
  • Understand the concepts of energy homeostasis and metabolic adaptation.
  • Discover the contributing factors that may influence energy homeostasis, such as genetic, behavioral, and environmental factors.
  • Understand how set points can be modified by medical or surgical interventions and the implications in treating patients with obesity.

9:00-10:15 AM - Impact of Psychotropic Medications on Obesity

Shannon L. Hillier, DO, MPH

  • Discover how to co-manage psychiatric diseases and obesity.
  • Learn about the interactions between anti-obesity medications and various medications for psychiatric disorders.
  • Understand the impact of psychotropic medications on weight.

10:15-10:30 AM - Break

10:30 AM-12:00 PM - Complex Cases in Obesity Treatment: Perspectives of Obesity Medicine Specialists

Angela Fitch, MD, FACP, FOMA, Dipl. ABOM, and Wickham Simonds, MD, FOMA, Dipl. ABOM

  • Hear the different perspectives of obesity medicine experts.
  • Review real-life case studies that these obesity medicine experts encountered in practice.
  • Understand why different treatment options were selected for certain patients with obesity and obesity-related conditions.
  • Ask your pressing questions regarding obesity and obesity-related disease treatment.
  • Understand how to apply what you've learned thoughout the conference in clinical practice.